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Oligodendrocyte precursor cells withdraw from the cell cycle and terminally differentiate after a limited number of cell
divisions. The timing of cell-cycle withdrawal and differentiation is controlled by an intrinsic timer, which consists of a
timing component that measures elapsed time and an effector component that arrests the cell cycle and initiates
differentiation. The effector component can be triggered by either thyroid hormone (TH) or retinoic acid (RA). In this study
we investigate how TH and RA act to trigger differentiation. We show the following: (1) Synthetic retinoids that can inhibit
AP-1 transcription factors but do not activate gene transcription cannot trigger the effector mechanism, suggesting that TH
and RA do not act only by inhibiting AP-1 activity as previously suggested. (2) Both TH and RA induce a transcriptionally
dependent antigenic change in purified precursor cells within 2–4 h. (3) Unexpectedly, even before they differentiate, the
precursor cells express ceramide galactosyltransferase (CGT), the enzyme that catalyzes the final step in the synthesis of
galactocerebroside, an early marker of oligodendrocyte differentiation. (4) Neither TH nor RA directly activates the
transcription of the CGT gene, a number of immediate early genes, or the genes that encode any of the known
cyclin-dependent kinase inhibitors. (5) The withdrawal of the mitogen platelet-derived growth factor (PDGF), but not TH
or RA treatment, causes a rapid decrease in c-fos, NGFI-A/Krox-24, and cyclin D2 mRNA, even though all three treatments
trigger cell-cycle arrest and differentiation. (6) PDGF withdrawal and TH treatment, but not RA treatment, induce an
increase in cyclin D3 mRNA within 4 h. Thus, we have not found any early changes in gene expression that occur with all
three treatments that trigger oligodendrocyte differentiation. © 1999 Academic Press
Key Words: Cdk inhibitors; ceramide galactosyltransferase; c-fos; D cyclins; immediate early genes; NGFI-A/Krox-24;
oligodendrocytes; PDGF; retinoic acid; thyroid hormone.INTRODUCTION
Oligodendrocyte precursor cells divide a limited number
of times before they terminally differentiate. Clonal analy-
ses of such cells isolated from the developing rat optic nerve
have suggested that a cell-intrinsic timer plays an impor-
tant part in determining when the cells stop dividing and
differentiate (Temple and Raff, 1986; Barres et al., 1994;
ao et al., 1997). At least two types of extracellular signal-
ng molecules are required for the timer to operate normally
n culture—the mitogen platelet-derived growth factor
PDGF) (Noble et al., 1988; Richardson et al., 1988; Raff et1 Present address: Department of Biochemistry, Baylor College of
Medicine, One Baylor Plaza, Houston, TX 77030.
0012-1606/99 $30.00
Copyright © 1999 by Academic Press
All rights of reproduction in any form reserved.al., 1988) and hydrophobic signals such as thyroid hormone
(TH) or retinoic acid (RA) (Barres et al., 1994). In the absence
of PDGF, the precursor cells rapidly stop dividing and
differentiate prematurely, whether or not TH or RA is
present (Barres et al., 1994). In the presence of PDGF and
the absence of hydrophobic signals, most of the cells tend to
keep dividing and do not differentiate; if TH is added to
such PDGF-stimulated cultures after 8 days, a time when
most of the precursor cells would have differentiated had
hydrophobic signals been present from the start, most of the
cells stop dividing and differentiate within 4 days (Barres et
al., 1994). These and other (Bo¨gler and Noble, 1994) findings
suggest that the intrinsic timer consists of at least two
components—a timing component that measures elapsed
time independently of hydrophobic signals and an effector
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328 Tokumoto, Durand, and Raffcomponent, which can be triggered by TH or RA, that stops
the cell cycle and initiates differentiation. There is evidence
that the cyclin-dependent protein kinase (Cdk) inhibitor
p27/Kip1 plays a part in both components (Casaccia-
Bonnefil et al., 1997; Durand et al., 1997, 1998).
It has long been known that TH plays an important part
n the timing of oligodendrocyte development in vivo:
yelination, for example, is retarded in hypothyroid ani-
als and accelerated in hyperthyroid animals (Walters and
orell, 1981; Legrand, 1986; Dussault and Ruel, 1987).
ore recently it has been shown that there are fewer
ligodendrocytes in the optic nerves of hypothyroid mouse
Ibarolla et al., 1996) and rat (Ahlgren et al., 1997) pups
ompared to normal pups. It remains uncertain, however,
ow TH stimulates oligodendrocyte precursor cells to dif-
erentiate.
Both TH and RA act by binding to nuclear receptors that
re members of the same superfamily of ligand-activated
ranscription factors (Evans, 1988; Mangelsdorf et al., 1995;
hambon, 1996). When activated by ligand binding, both
H receptors and RA receptors (RARs) can also repress the
ctivity of AP-1 transcription factors (Diamond et al., 1990;
erppola et al., 1993; Nicholson et al., 1990; Schule et al.,
991; Yang-Yen et al., 1990; Zhang et al., 1991), which are
imers of members of the Jun and Fos families (Karin et al.,
997; Angel and Karin, 1991). As some AP-1 dimers help
ediate the proliferative response to growth factors in
any cell types (Ransone and Verma, 1990; Angel and
arin, 1991; Riabowol et al., 1992; Johnson et al., 1992,
993; Wang et al., 1992), it was proposed that both TH and
A may activate the effector component of the timer in
ligodendrocyte precursor cells by inhibiting AP-1 activity
Barres et al., 1994; Raff and Barres, 1994). This proposal
as supported by the finding that the phorbol ester 12-O-
etradecanoylphorbal 13-acetate, which activates protein
inase C and enhances the activity of AP-1, antagonizes the
bility of TH to activate the effector mechanism (Barres et
l., 1994).
In the present study we first tested the AP-1 hypothesis
y using synthetic retinoids that are as potent as RA in
ctivating the AP-1-repressive function of RARs but are
efective in stimulating the transactivation function of
hese receptors (Chen et al., 1995). We find that these
etinoids are unable to substitute for RA or TH in promot-
ng oligodendrocyte differentiation in optic nerve cultures,
ndicating that repression of AP-1 activity is not sufficient
o activate the effector mechanism in oligodendrocyte pre-
ursor cells. This finding suggests that TH and RA stimu-
ate oligodendrocyte differentiation, at least in part, by
irectly regulating gene transcription. Consistent with this
uggestion, we show that TH induces an antigenic change
n the surface of purified precursor cells within 2–4 h and
hat this change is inhibited if RNA synthesis is suppressed.
e have therefore used RT-PCR to look for rapid changes in
he expression of a number of candidate genes when puri-
ed precursor cells are either treated with TH or RA or
eprived of PDGF. We have examined several immediate
T
t
Copyright © 1999 by Academic Press. All rightarly genes, all of the genes that encode known Cdk
nhibitors, and the gene that encodes ceramide galactosyl-
ransferase (CGT), which catalyzes the final step in the
ynthesis of galactocerebroside (GC), an early marker of
ligodendrocyte differentiation. We find that none of these
enes are activated at 1, 4, or 8 h after treatment with TH,
A, or PDGF withdrawal, although the mRNAs of two
mmediate early genes, c-fos and NGFI-A/Krox-24, rapidly
ecrease upon PDGF withdrawal, but not upon TH or RA
reatment. Thus, at least some of the early changes in gene
xpression induced by PDGF withdrawal are different from
hose induced by TH or RA, although all of these treat-
ents result in cell-cycle arrest and differentiation. Finally,
e show that PDGF withdrawal, but not TH or RA treat-
ent, rapidly decrease cyclin D2 mRNA, while PDGF
ithdrawal and TH treatment, but not RA treatment,
ncrease cyclin D3 mRNA within 4 h. Thus, there are
ifferences between all of the three treatments in terms of
he early changes in gene expression that they induce.
MATERIAL AND METHODS
Animals and materials. Sprague/Dawley rats were obtained
from the breeding colony of University College London. All chemi-
cals were from Sigma, unless otherwise indicated. Recombinant
human PDGF-AA and neurotrophin-3 (NT-3) were purchased from
Peprotech. The synthetic retinoids BMS 453 and BMS 493 were
kindly provided by P. Chambon and H. Gronemeyer (Chen et al.,
1995); they and all-trans RA were made up in ethanol at a
concentration of 1 mM. Affinity-purified rabbit anti-CGT poly-
clonal antibodies (A56) were kindly provided by Wilhelm Stoffel.
Mixed optic nerve cultures. Optic nerves were removed from
neonatal (P0) rats, dissociated in trypsin, and cultured on poly-D-
lysine (PDL)-coated glass coverslips (25,000 cells per coverslip) in
modified Bottenstein-Sato (B-S) medium (Bottenstein and Sato,
1979; Lillien and Raff, 1990) in 5% CO2 at 37°C, as previously
described (Durand et al., 1997). Forskolin and PDGF-AA were
added to a final concentration of 15 mg/ml and 10 ng/ml, respec-
tively, while in some cultures TH was added as triiodothyronine
and thyroxine at 40 ng/ml each, or RA, BMS 453, or BMS 493 was
added at a final concentration of 0.5 mM. Half of the medium was
changed every 2 days.
Cultures of purified oligodendrocyte precursor cells. Optic
nerve cells were prepared from P0 and P7 optic nerves, and
oligodendrocyte precursor cells were purified by sequential im-
munopanning, as previously described (Barres et al., 1992). The
purified precursor cells (1000–2000 cells in 3 ml of culture me-
dium) were cultured in PDL-coated 25-cm2 flasks (Falcon) in B-S
medium containing N-acetylcysteine (60 mg/ml), forskolin (5 mM),
race minerals (GIBCO), PDGF-AA (10 ng/ml), NT-3 (5 ng/ml), and
enicillin and streptomycin (GIBCO). In some experiments the
urified cells were cultured in PDL-coated Nunc slide flasks (500
ells in 2 ml of culture medium), while in others they were
ultured on PDL-coated glass coverslips (1000 cells per coverslip) in
4-well Falcon culture plates.
Immunofluorescence staining. Mixed optic nerve cells growing
n PDL-coated glass coverslips were immunostained after 5 days.
he cells were fixed in 2% paraformaldehyde for 3 min at room
emperature. After washing, they were incubated for 15 min in
s of reproduction in any form reserved.
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329Early Events in Oligodendrocyte Differentiation50% normal goat serum to block nonspecific staining. They were
then incubated in the A2B5 monoclonal antibody (Eisenbarth et al.,
979; ascitic fluid, diluted 1:100), followed by Texas-Red-coupled
oat anti-mouse IgM (Accurate; diluted 1:100). They were then
ncubated in monoclonal anti-GC antibody (Ranscht et al., 1982;
scitic fluid, diluted 1:100), followed by fluorescein-coupled goat
nti-mouse IgG3 (Nordic; diluted 1:100). All incubations were for
5 min at room temperature, and the dilutions were in Tris-
uffered saline containing 1% bovine serum albumin and 10 mM
L-lysine. Finally, the coverslips were postfixed in acid/alcohol, mounted
in Citifluor mounting medium (CitiFluor, UK), sealed with nail vanish,
and examined with a Zeiss Axioskop fluorescence microscope.
Purified precursor cells growing on PDL-coated slide flasks were
fixed in paraformaldehyde and then treated with the Ranscht or O1
monoclonal anti-GC antibodies as above. After washing, the
Ranscht-antibody-treated cells were incubated with biotin-
conjugated goat anti-mouse IgG antibody (Amersham; diluted
1:100), while O1-antibody treated cells were incubated with biotin-
conjugated goat anti-mouse IgM antibody (Amersham; diluted
1:100). After washing in phosphate-buffered saline, the cells were
stained with fluorescein-conjugated streptavidin (Amersham; di-
luted 1:100). In some cases the cells were labeled with A2B5
antibody as described above, before they were stained for GC. For
CGT staining, purified precursors growing on PDL-coated glass
coverslips were fixed in cold acid/alcohol for 10 min and then
blocked with 50% horse serum for 30 min at room temperature.
After washing, the cells were incubated in affinity-purified rabbit
anti-CGT polyclonal antibodies, followed by biotin-conjugated
donkey anti-rabbit Ig (Amersham; diluted 1:100) and streptavidin–
fluorescein. All incubations were for 30 min at room temperature.
Preparation of cDNA from purified oligodendrocyte precursor
cells. Purified oligodendrocyte precursor cells were removed from
the culture flasks with trypsin after 10 days in culture in PDGF
without TH. In some cases the cells were treated with TH
(triiodothyronine, 40 ng/ml; thyroxine, 40 ng/ml) or RA (all-trans
retinoic acid, 300 ng/ml) for 1, 4, or 8 h before they were harvested;
in other cases, the cells were washed well and cultured without
PDGF, TH, or RA for the same period before they were harvested.
About 6 3 104 cells were harvested from each flask. Poly(A)1
mRNA was prepared using a QuickPrep Micro mRNA Purification
kit (Pharmacia Biotech, Uppsala, Sweden), according to the suppli-
er’s instructions. The RNA was then dissolved in doubly distilled
water (DDW), and cDNA synthesis was carried out using a SMART
PCR cDNA Synthesis kit (Clontech Laboratories, Palo Alto, CA),
according to the supplier’s instructions. In brief, first-strand cDNA
synthesis was carried out using oligo(dT) reverse transcriptase
primers. Each strand synthesised contained the unique sequence
59AAGCGTGGTAACAACGCAGAGT39 for PCR amplification at
its 59 end. Because of the character of the MMLV reverse transcrip-
tase (Superscript II, GIBCO BRL), the 39 end of the first strand of
each cDNA contained a poly(C) tail. The second oligonucleotide,
SMART II oligonucleotide (59AAGCGTGGTAACAACGCAGAG-
TACGCGGG39), which has the same unique sequence for PCR
amplification at its 59 end, annealed to the poly(C) tail of the first
strand and the fill-in reaction was carried out. The PCR reaction
was carried out, and the amplified total cDNA was used as the
template for the RT-PCR reaction. Before performing the PCR
reaction, the amplified cDNA samples were all electrophoresed in
the same 1% agarose gel, stained with ethidium bromide (EtBr, 0.4
mg/ml), and normalized according to the intensity of staining.RT-PCR. The following oligonucleotide DNA primers were
synthesized: For p15/INK4b, the 59 primer was 59GCAGCAGT-
Copyright © 1999 by Academic Press. All rightACGCGGG39 and the 39 primer was 59AGCGTGTCCAG-
AAGCC39. For p16/INK4a the 59 primer was 59TCGC-
C C A A C G C C C C G A A 3 9 a n d t h e 3 9 p r i m e r w a s
59ATCGCGCACATCCAGCC39. For p19ARF, the 59 primer was
59TGGGTCGCAGGTTCTTGG39 and the 39 primer was
59ATCGCGCACATCCAGCC39. For p18/INK4c, the 59 primer was
59GCAACTTACTAGTTTGTTGC39 and the 39 primer was 59AG-
GCTGTGTGCTTCATAAG39. For p19/INK4d, the 59 primer was
59AGCTGGTGCATCCTGAC39 and the 39 primer was 59GGTG-
GAGATCAGATTCAG39. For p21/Cip1, the 59 primer was
59CAATACGTCTGGGAGC39 and the 39 primer was 59CTTGCA-
GAAGACCAATCG39. For p27/Kip1, the 59 primer was 59AGCT-
TGCCCGAGTTCTAC39 and the 39 primer was 59TCCACAGT-
GCCAGCATTC3 9 . For p57/Kip2, the 5 9 primer was
59TACCGCGAGACGGTGCAG39 and the 39 primer was 59GT-
TCTCTTGCGCTTGGCG39. For CGT, the 59 primer was 59ATGT-
TATGTACTGACGTAGC39 and the 39 primer was 59ATACTGT-
TCAAACCACCATG3 9 . For c-fos , the 5 9 primer was
59GACTACGAGGCGTCATCC39 and the 39 primer was
59CCGATGCTCTGCGCTCTG39. For ICRE, the 59 primer was
59CAGGTGACATGCCAACTTAC39 and the 39 primer was
59GTTTTTCATCAGCCTCAGC39. For NGFI-A/Krox-24, the 59
primer was 59AGATGATGCTGCTGAGCAAC39 and the 39
primer was 59CCACAAAGTGTTGCCACTG39. For c-myc, the 59
primer was 59TGTACCTGCAGGACCTCAC39 and the 39 primer
was 59TGACTCGGACCTCTTGGC39. For c-jun, the 59 primer
was 59CTAAGATTCTGAAGCAGAGC39 and the 39 primer was
59GGCTATGCAGTTCAGCTAG39. For jun-B, the 59 primer was
59CAACCTGGCAGATCCTTATC39 and the 39 primer was
59CACGTGGTTCATCTTCTGC39. For cyclin D1, the 59 primer
was TGGAACACCAGCTCCTGTG39 and the 39 primer was 59TC-
CTTCATCTTAGAGGCCAC39. For cyclin D2, the 59 primer was
59CTGTGCTGTGAGGTGGAC39 and the 39 primer was 59CTAG-
GAACATGACCACAGC39. For cyclin D3, the 59 primer was 59CT-
GTGTTGCGAGGGCACC39 and the 39 primer was 59GTACCTA-
GAAGCTGCAGTTG39. For cyclin E, the 59 primer was
59CCAGGATAGCAGTCAGCC39 and the 39 primer was 59CTC-
CATCAGCCAGTCCAG39. For glyceraldehyde-3-phosphate dehy-
drogenase (G3PDH), the 59 primer was 59ACCACAGTCCATGC-
CATCAC39 and the 39 primer was 59TCCACCACCCTGT-
TGCTGTA.
All primers were dissolved in TE buffer. The RT-PCR reaction was
carried out as follows: 25 ml of reaction mixture contained 200 pg of
PCR-amplified total cDNA as template, 300 nM 59 PCR primer, 300
nM 39 PCR primer, 0.2 mM dNTP, 1.25 mM MgCl2, 10 mM Tris–HCl
(pH 9.0), 50 mM KCl, 0.1% Triton X-100, and 1.25 units of Taq DNA
polymerase (Promega Corporation, Madison, WI). The reaction mix-
ture was denatured for 1 min at 94°C. The PCR reaction was then
started, using 94°C for 15 s for the denaturing step, 53°C for 30 s for
the annealing step, and 72°C for 1 min for the elongation step. To
determine how many PCR cycles to use, we removed 10 ml of each
reaction mixture after 30 cycles, electrophoresed it in 2% agarose gel,
and stained it with EtBr; depending on the intensity of staining, we
either stopped the reaction at 30 cycles, continued for several more
cycles, or started again and stopped before 30 cycles.
RESULTS
Effect of Retinoids
The synthetic retinoids BMS 453 and BMS 493 have been
shown to have impaired transactivation function when
s of reproduction in any form reserved.
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330 Tokumoto, Durand, and Rafftested at 0.5 mM on reporter cell lines containing the
DNA-binding domain of the yeast transactivator Gal 4
fused to the ligand-binding and AF-2-activating domains of
the RA receptors RARa, RARb, or RARg (Chen et al., 1995;
P. Chambon and H. Gronemeyer, personal communica-
tion). When tested on cells containing an AP-1 reporter
gene, however, both BMS 453 and BMS 493 have potent
AP-1 inhibitory activity (Chen et al., 1995). We tested these
retinoids on mixed cultures of neonatal rat optic nerve
cells, prepared and cultured in serum-free medium and
saturating amounts of PDGF-AA, as previously described
(Durand et al., 1997). RA, BMS 453, or BMS 493 (all at 0.5
mM) or TH was added to some of the cultures. After 5 days,
the cells were fixed and assessed by a indirect immunoflu-
orescence, using the A2B5 monoclonal antibody (Eisen-
barth et al., 1979) to detect oligodendrocyte precursor cells
(Raff et al., 1983) and a monoclonal anti-galactocerebroside
(GC) antibody (Ranscht et al., 1982) to detect oligodendro-
cytes (Raff et al., 1978), as previously described (Durand et
al., 1997).
As shown in Fig. 1, less than 5% of the oligodendrocyte
precursor cells differentiated into GC1 oligodendrocytes in
ither the absence of hydrophobic signals or in the presence
FIG. 1. Effect of retinoids. Mixed optic nerve cells from P0 rats
were cultured on PDL-coated glass coverslips in B-S medium
containing PDGF. The synthetic retinoids BMS 453 or BMS 493
were added at a final concentration of 0.5 mM to some cultures. As
positive controls, TH, as triiodothyronine and thyroxine (40 ng/ml
of each), or all- trans RA (0.5 mM) was added to some cultures. As
negative control, the solvent (ethanol) was added to some cultures
t the same final concentration (0.05%). After 5 days, the cells were
xed and stained with the Ranscht anti-GC antibody to identify
ligodendrocytes and with A2B5 antibody to identify oligodendro-
yte precursors. The results are shown as means 6 SD of at least
three independent experiments.f either BMS 453 or BMS 493, whereas 25–35% differenti-
ted in the presence of either RA or TH. As both BMS 453
Copyright © 1999 by Academic Press. All rightnd BMS 493 were toxic when used at .1 mM on P0 cells,
we repeated the experiments with P7 optic nerve cells using
higher concentrations of both retinoids: BMS 453 was still
ineffective at inducing oligodendrocyte differentiation at 1
or 5 mM and was toxic at 10 mM, while BMS 493 was
inefective at 1 mM and was toxic at 5 mM (not shown). Thus,
neither BMS 453 nor BMS 493 could mimic the effect of TH
or RA in triggering oligodendrocyte differentiation. This
finding suggests that the AP-1-repressive activity of RARs
or TH receptors is not sufficient to activate the effector
component of the timer in oligodendrocyte precursor cells.
Brief Treatment with TH
To determine how long a period of TH treatment is
required to trigger the effector mechanism, we purified
precursor cells from P7 rat optic nerve by sequential immu-
nopanning (Barres et al., 1992) and cultured them in culture
flasks in PDGF, in the absence of TH and RA. After 10 days,
some of the flasks were treated with TH for 30 min or 1 h;
the treated and untreated cells were then removed from the
flasks with trypsin, washed, and recultured with or without
TH for a further 3 days. The proportion of cells that had
differentiated into oligodendrocytes, as judged by their
highly characteristic morphology (Raff et al., 1978), was
then determined. As shown in Fig. 2, the proportion of
precursor cells that differentiated into oligodendrocytes
after 3 days was the same whether the cells were treated
with TH for 1 h or for the entire 3 days; even with only 30
min of TH treatment, most of the cells differentiated into
oligodendrocytes.
Rapid Antigenic Change Induced by TH
To determine how quickly TH induces a detectable anti-
genic change in oligodendrocyte precursor cells, we cultured
purified precursor cells in slide flasks for 10 days in PDGF, in
the absence of TH and RA, and then added TH to some of the
flasks for 1, 4, or 8 h. No morphological changes could be
detected at these times. The treated and untreated cells were
then fixed in paraformaldehyde and stained on their surface by
indirect immunofluorescence with the monoclonal anti-GC
antibody (Ranscht et al., 1982). Between 20 and 40% of the
untreated cells showed a speckled patch of staining on one
side of the cell body (Figs. 3A and 3B); this proportion was
significantly increased by 2 h of TH treatment and more than
doubled by 4 h (Fig. 4A). The increase was inhibited if the cells
were pretreated with the RNA synthesis inhibitor actinomy-
cin D for 90 min before the TH treatment (Fig. 4B), suggesting
that the increase depended on new gene transcription. RA
mimicked the effect of TH, and actinomycin D also inhibited
this effect (not shown). Surprisingly, similar staining was not
seen when the O1 monoclonal anti-GC antibody (Sommer
and Schachner, 1981) was used instead of the Ranscht mono-
clonal anti-GC antibody (Figs. 3D and 3E), even though the 01
antibody stained oligodendrocytes as intensely as did the
Ranscht antibody (Figs. 3C and 3F). The O1 antibody weakly
s of reproduction in any form reserved.
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331Early Events in Oligodendrocyte Differentiationstained a small proportion (,10%) of the precursor cells on
ne process (Fig. 3E), but this proportion did not increase with
H treatment (not shown). These findings suggest that the
atches stained by the Ranscht antibody are not GC, but
erhaps a related glycolipid such as sulfatide, which the
anscht antibody, but not O1, has been shown to recognize
Bansal et al., 1989).
Whatever the nature of the antigen, it is clear that both
H and RA treatment can induce a change in antigen
xpression within 2–4 h by a mechanism that depends on
ene transcription. The proportion of precursor cells ex-
ressing the antigen patch peaked at 4 h and returned to
ormal levels by 17 h (not shown). By 17 h, however, some
f the cells had adopted an oligodendrocyte morphology; by
days more than 95% had done so, and the majority of
hese stained diffusely on their body and processes with
ither of the two anti-GC antibodies (Figs. 3C and 3F).
Ceramide Galactosyltransferase (CGT)
FIG. 2. Effect of a short exposure to TH. Purified P7 oligodendrocyte
recursor cells were cultured in flasks for 10 days in B-S medium
ontaining PDGF but no TH. The cells were then treated with TH
triiodothyronine and thyroxine, both at 40 ng/ml) for 30 or 60 min,
fter which they were removed from the flask with trypsin, washed
wice, and recultured for 3 days, with or without TH. The proportion
f cells that had acquired an oligodendrocyte morphology was deter-
ined, and the results were normalized to the proportion in cultures
aintained in TH for the final 3-day culture. The results are shown as
eans 6 SD of three experiments.CGT catalyzes the final step in the synthesis of GC,
which is then sulfated to form sulfatide. As a GC-related
Copyright © 1999 by Academic Press. All rightlycolipid seemed to be induced by TH within 2–4 h in
any oligodendrocyte precursor cells, we used RT-PCR to
est whether TH increased CGT mRNA expression. As
hown in Fig. 5A, CGT mRNA was readily detected in
purified precursor cells, but its level did not detectably
increase at 1, 4, or 8 h after TH treatment. By 3 days after
TH treatment, however, when almost all of the cells had
differentiated into oligodendrocytes, CGT mRNA was
greatly increased (Fig. 5A).
As CGT has been reported to first be expressed around
the time that myelination begins (Schulte and Stoffel,
1993), it was somewhat surprising to find CGT mRNA
expressed in oligodendrocyte precursor cells. To determine
whether the precursor cells expressed CGT protein, as well
as mRNA, we cultured purified precursor cells in PDGF
without TH and RA for 10 days on PDL-coated glass
coverslips and stained them with affinity-purified rabbit
anti-CGT antibodies produced against (and purified on) a
peptide corresponding to residues Asn 334–Ala 354 of the
CGT protein (W. Stoffel, unpublished). Approximately 40%
of the cells were stained in their cytoplasm by the antibod-
ies (Fig. 5B). Neither the proportion of cells stained nor the
intensity of staining increased after 8 h treatment with TH
(not shown), but the staining was stronger in oligodendro-
cytes that differentiated in response to TH treatment for 2
days (Fig. 5C). Thus, many oligodendrocyte precursor cells
express both CGT mRNA and protein before they differen-
tiate, although both increase after differentiation.
Immediate Early Genes
A large number of genes have been shown to be rapidly
induced in response to extracellular signals, such as those
present in serum (Iyer et al., 1999). The responses that occur
ithin minutes and are not blocked by inhibitors of protein
ynthesis such as cycloheximide are referred to as immedi-
te early genes. We used RT-PCR to determine if six known
mmediate early genes—c-fos, c-jun, jun-B, c-myc, ICRE,
nd NGFI-A/Krox-24—were induced when purified oligo-
endrocyte precursor cells maintained in PDGF without
H and RA for 10 days were treated with TH, RA, or PDGF
ithdrawal for 1, 4, or 8 h. The mRNAs corresponding to
hese genes were detectable, but none of them seemed to
ncrease significantly after any of the three treatments. The
esults with TH treatment are shown in Fig. 6A. The c-fos
and NGFI-A/Krox-24 mRNAs, however, rapidly decreased
after PDGF withdrawal (Fig. 6B), but not after TH or RA
treatment (not shown), indicating that these treatments are
not equivalent in terms of the immediate early gene re-
sponses they induce, even though they all lead to oligoden-
drocyte differentiation.
Cdk Inhibitor Genes
In some cell lineages, including the oligodendrocyte cell
lineage, Cdk inhibitors are thought to play an important
part in helping precursor cells to withdraw from the cell
s of reproduction in any form reserved.
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332 Tokumoto, Durand, and Raffcycle and differentiate. We therefore used RT-PCR to deter-
mine which of the known Cdk inhibitor genes are expressed
by purified oligodendrocyte precursors and whether any of
these are directly activated by TH. Two families of Cdk
inhibitors have been identified in mammalian cells—the
Ink4 family, which includes p16/INK4a (p16), p15/INK4b
(p15), p18/INK4c (p18), and p19/INK4d (p19), and the Cip/
Kip family, which includes p21/Cip1 (p21), p27/Kip1 (p27),
and p57/Kip2 (p57) (Sherr and Roberts, 1995). In addition,
the p16/Ink4a locus encodes an unrelated cell-cycle inhib-
itor called p19ARF in rodents (Quelle et al., 1995). When
RNA was extracted from purified P7 oligodendrocyte pre-
cursor cells that had been growing in PDGF in the absence
of TH and RA for 10 days, mRNAs for all of these inhibitors
FIG. 3. Patch staining with the Ranscht anti-GC antibody. Purifi
PDGF but no TH. In (A), (B), (D), and (E) the cells were treated wit
by indirect immunofluorescence with the antibodies indicated. Th
and (F) the cells were treated with TH for 3 days to induce them tcould be detected by RT-PCR. When TH or RA was added to
the cultures or PDGF was withdrawn for 1, 4, or 8 h, none
Copyright © 1999 by Academic Press. All rightf the mRNAs detectably increased, suggesting that TH did
ot directly activate any of these genes. The results for TH
re shown in Fig. 7.
Cyclin D and Cyclin E
In principle, TH and RA could induce cells to withdraw
from the cell cycle and differentiate by decreasing the level
of a G1 cyclin such as a cyclin D or cyclin E, which are
required for progression through G1 and into S phase. We
therefore used RT-PCR to study the effect of TH, RA, or
PDGF withdrawal on the mRNA that encode cyclins D1,
D2, D3, and E. As shown in Fig. 8, all of these mRNAs were
expressed in the ologodendrocyte precursor cells. The levels
ecursor cells were cultured for 10 days in B-S medium containing
for 2 h and then fixed in paraformaldehyde for 4 min and stained
e precursor cells are shown in (A) and (B) and in (D) and (E). In (C)
ome oligodendrocytes.ed pr
h THof cyclin D1 and cyclin E mRNA were not changed during
8 h by any of these treatments. Cyclin D2 mRNA was
s of reproduction in any form reserved.
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333Early Events in Oligodendrocyte Differentiationrapidly decreased with PDGF withdrawal, but not with TH
or RA treatment. Surprisingly, cyclin D3 mRNA was in-
reased at 4 and 8 h after the withdrawal of PDGF or TH
reatment (Fig. 8), but not after RA treatment (not shown).
DISCUSSION
We show here that synthetic retinoids that can stimulate
the AP-1 repressive function but not the transactivation
function of RARs (Chen et al., 1995) are unable to activate
the effector mechanism that causes PDGF-stimulated oli-
godendrocyte precursor cells in culture to stop dividing and
differentiate. This finding makes it unlikely that our origi-
nal hypothesis that RA and TH act to trigger oligodendro-
cyte differentiation by inhibiting AP-1 activity (Barres et
l., 1994; Barres and Raff, 1994) is correct. It suggests
nstead that both of these signaling molecules trigger oligo-
endrocyte differentiation, in part at least, by directly
egulating gene transcription. We have therefore gone on to
tudy a number of candidate genes to see if they are directly
egulated by TH or RA, or by PDGF withdrawal, which is
nother way of triggering oligodendrocyte differentiation.
irst, however, we investigated how long it is necessary to
reat precursor cells with TH to trigger oligodendrocyte
FIG. 4. Timing and actinomycin-D sensitivity of TH-induced pa
flasks in B-S medium containing PDGF but no TH. In (A) the cells
A2B5 and the Ranscht antibody to determine the proportion of pre
(B), some of the cells were pretreated with actinomycin D (AD, 0.5
as means 6 SD of at least three cultures.ifferentiation and how quickly the precursors change in
esponse to TH or RA treatment.
Copyright © 1999 by Academic Press. All rightBrief Treatment and a Rapid Antigenic Change
When precursors are treated with TH for as little as
30–60 min and then removed from the culture flask with
trypsin, washed, and recultured for a further 3 days, the
majority of cells are induced to differentiate. This finding
indicates that TH treatment is only required for a brief
period to trigger the effector mechanism that eventually
arrests the cell cycle and initiates differentiation. This may
be because TH rapidly induces its primary response genes,
which then trigger the next steps in the response indepen-
dently of TH, so that TH is no longer needed; alternatively,
TH may remain bound to its receptors and continue to
regulate transcription of its target genes long after TH has
been removed from the culture medium.
To determine how rapidly TH or RA treatment induces
GC expression in purified precursor cells, we have stained
cells with the Ranscht monoclonal anti-GC antibody (Ran-
scht et al., 1982) at various times after these treatments. As
expected, typical diffuse cell-surface GC staining is only
seen in cells that have differentiated and acquired a typical
multiprocessed oligodendrocyte morphology and is first
detectable in some cells at around 17–20 h after TH treat-
ment. Unexpectedly, however, we find that, well before
precursor cells have been induced to change their morphol-
taining. Purified precursor cells were cultured for 10 days in slide
then treated with TH for 2 or 4 h and then fixed and stained with
or cells that showed patch staining with the Ranscht antibody. In
l) for 90 min before TH treatment for 4 h. The results are showntch s
were
cursogy, some of the cells show a speckled patch of staining on
one side of the cell body. Although 20–40% of untreated
s of reproduction in any form reserved.
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334 Tokumoto, Durand, and Raffprecursors stain in this way, the proportion increases
within 2 h of treatment with either TH or RA, doubles by
4 h, and returns to normal levels by 17 h. Pretreatment of
the cells with the RNA synthesis inhibitor actinomycin D
suppresses the increase, suggesting that the increase de-
pends on new gene transcription.
The patch staining seems not to be due to GC, as it is not
FIG. 5. CGT expression in precursor cells. (A) Purified precursor
treated with TH for the times indicated, after which RNA was p
template, as described under Materials and Methods. The PCR reac
using G3PDH primers. G3PDH is a housekeeping gene and was st
on PDL-coated glass coverslips in B-S medium containing PDGF
affinity-purified anti-CGT antibodies. (C) Purified precursor cells w
cells were then stained as in (B).seen when the O1 monoclonal anti-GC antibody is used
instead of the Ranscht antibody. As the Ranscht antibody,
t
i
Copyright © 1999 by Academic Press. All rightut not O1, has been shown to recognize sulfatide, as well
s GC (Bansal and Pfeiffer, 1989), it is possible that the
atches are sulfatide, which has been reported to appear
efore GC during oligodendrocyte differentiation (Bansal
nd Pfeiffer, 1994a).
Interestingly, treatment with the Ranscht antibody has
een shown to reversibly inhibit oligodendrocyte differen-
were cultured for 10 days in culture flasks. The cells were then
red. RT-PCR was carried out using PCR-amplified cDNA as the
was carried out for 28 cycles using CGT primers and for 23 cycles
as a control. (B) Purified precursor cells were cultured for 5 days
no TH. They were then fixed in acid-alcohol and stained with
ultured as in (B) for 3 days and then in TH for another 2 days. Thecells
repa
tion
udied
butiation in culture, whereas the O1 antibody fails to inhibit
n the same assay (Bansal and Pfeiffer, 1989). Moreover, the
s of reproduction in any form reserved.
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335Early Events in Oligodendrocyte DifferentiationRanscht antibody, but not O1, induces mature oligodendro-
cytes in culture to retract their processes and to down-
regulate myelin-specific gene expression (Bansal and
Pfeiffer, 1994b). These findings raise the possibility that the
patch staining we see with the Ranscht antibody is func-
tionally significant. Consistent with this possibility, the
Ranscht antibody has also been shown to completely block
myelination in cocultures of oligodendrocytes and sensory
neurons (Ranscht et al., 1987), even though oligodendro-
ytes develop and myelination occurs in mice that are
eficient in CGT and therefore cannot make GC or sul-
atide; the myelin in these mice, however, is functionally
bnormal (Coetzee et al., 1996; Bosio et al., 1996).
Expression of CGT in Oligodendrocyte Precursors
FIG. 6. Expression patterns of immediate early genes. Purified pre
containing PDGF but no TH. The cells were then treated with TH
was prepared and RT-PCR carried out as in Fig. 5. The number of
c-jun and jun-B, and 23 for G3PDH.Although the chemical nature of the antigenic patches
induced by TH or RA treatment is uncertain, there is a strong
d
s
Copyright © 1999 by Academic Press. All rightossibility that it is a galactolipid such as sulfatide. Since the
roduction of both GC and sulfatide depends on CGT, we
ave studied the expression of CGT mRNA and protein in
urified oligodendrocyte precursor cells and find that both are
xpressed. As CGT mRNA and protein have previously been
eported to first appear in ontogeny around the time that
yelination begins (Schulte and Stoffel, 1993), we had ex-
ected to find them in oligodendrocytes but not in their
recursors. To our knowledge, this is the first demonstration
hat CGT is made by oligodendrocyte precursors before they
ifferentiate, although the expression of both the mRNA and
rotein increases after the precursors differentiate.
Importantly, neither the expression of CGT mRNA nor the
xpression of CGT protein increases after 4 h of TH treat-
ent, which is a time when the proportion of precursor cells
howing patch staining with the Ranscht antibody has
or cells were cultured for 10 days in culture flasks in B-S medium
or deprived of PDGF (B) for the times indicated, after which RNA
cycles was 30 for c-fos, c-myc, ICRE, and NGFI-A/Krox-24, 35 forcurs
(A)oubled with this treatment. Thus, the induction of patch
taining seems not to reflect an increase in CGT mRNA or
s of reproduction in any form reserved.
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336 Tokumoto, Durand, and Raffprotein expression; if the staining depends on CGT, it must
reflect a posttranslational change in either the enzyme or one
or more of its products. In either case, the induction seems to
depend on new gene transcription, as discussed above.
Immediate Early Genes
FIG. 7. Expression patterns of Cdk inhibitor genes. The cells were
grown and assayed as described in the legend to Fig. 6. The number
of PCR cycles was 40 for p57/Kip2; 30 for p15/INK4b, p16/INK4a,
and p21/Cip1; 28 for p19ARF and p27/Kip1; 25 for p18/INK4c and
19/INK4d; and 23 for G3PDH.We have used RT-PCR to examine a number of candidate
genes that might be activated in purified precursor cells
Copyright © 1999 by Academic Press. All rightithin 1–8 h by treatment with TH, RA, or PDGF with-
rawal. We have analyzed six immediate early genes, in-
luding c-myc, c-fos, c-jun, jun-B, ICRE, and NGFI-A/Krox-
4. Although all of these mRNAs are detectable in the
recursor cells, none are detectably increased at 1, 4, or 8 h
fter any of the treatments. Two mRNAs—c-fos and NGFI-
/Krox-24—decrease within 1 h of PDGF withdrawal, but
ot after TH or RA treatment, indicating that at least some
f the early changes in gene expression induced by PDGF
ithdrawal are different from those induced by TH or RA
reatment, even though all of these treatments lead to
ell-cycle arrest and differentiation. Nonetheless, it is pos-
ible that the decrease in c-fos and NGFI-A/Krox-24 expres-
sion plays a part in arresting the cell cycle in response to
PDGF deprivation. Our findings are somewhat different
from those of a previous study that found that mitogen
withdrawal induced an increase in NGFI-A/Krox-24 mRNA
at 1 h, followed by a decrease at 3 h, in the oligodendrocyte
precursor cell line CG4 (Sock et al., 1997). This may reflect
a difference between normal cells and an immortal cell line.
Cdk Inhibitors
There is increasing evidence that the Cdk inhibitor p27 is
one part of the cell-intrinsic timer that regulates when
oligodendrocyte precursors withdraw from the cell cycle
FIG. 8. The expression patterns of G1 cyclin genes. The cells were
grown and assayed as described in the legend to Fig. 6. The number
of PCR cycles was 28 for cyclins D2 and D3, 27 for cyclins D1 and
E, and 23 for G3PDH.
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337Early Events in Oligodendrocyte Differentiationand terminally differentiate when stimulated by PDGF in
culture: (1) the level of p27 protein progressively increases
with the expected time course as precursor cells proliferate
(Durand et al., 1997); (2) the timer runs faster at 33°C than
at 37°C, and p27 levels rise faster at the lower temperature
(Gao et al., 1997); and (3) oligodendrocyte precursor cells
isolated from p27-deficient mice divide with a normal
cell-cycle time, but many of them go through one or two
more divisions before they differentiate than do wild-type
cells (Durand et al., 1998), and they differentiate more
lowly when deprived of mitogen (Casaccia-Bonnefil et al.,
997; Durand et al., 1998). One way that TH or RA might,
n principle, trigger the effector component of the timer
ould be to increase the production of another Cdk inhib-
tor, which might cooperate with p27 to arrest the cell cycle
n G1 and initiate differentiation. Casaccia-Bonnefil et al.
1997) have shown that p21, like p27, is expressed by
ligodendrocyte lineage cells.
We have therefore investigated whether any of the known
dk inhibitor genes are induced by TH or RA treatment or
DGF withdrawal. We find that mRNAs encoding each of
he known Cdk inhibitors can be detected by RT-PCR in
urified oligodendrocyte precursors in culture, but none of
hese detectably increase when the cells are treated with
H, RA, or PDGF withdrawal for 1, 4, or 8 h. Thus, it seems
nlikely that any of these genes are directly activated by
H or RA.
It was recently found that the phenotype of mice defi-
ient in the p18/Ink4c Cdk inhibitor is remarkably similar
o that of p27-deficient mice (Franklin et al., 1998): in both
ases the mice are about 30% larger than wild-type mice
ecause they have more cells in most of their organs (Fero et
l., 1996; Kiyokawa et al., 1996; Nakayama et al., 1996).
Moreover, in mice that are deficient in both p27 and p18
some organs are even larger than they are in mice deficient
in either protein alone (Franklin et al., 1998). Our findings
that p18 mRNA is expressed in oligodendrocyte precursor
cells raises the possibility that p18 is also part of the timer
that regulates the timing of oligodendrocyte precursor dif-
ferentiation. The advantage of such a multicomponent
mechanism is that it is both accurate and robust; if one or
two components are defective, the mechanism still works,
although less accurately (Raff et al., 1998).
Cyclins
To determine whether TH or RA triggers cell-cycle arrest
by directly inhibiting the transcription of one or more genes
encoding G1 cyclins, we have used RT-PCR to examine the
effect of TH and RA on G1 cyclin mRNAs. We find that
cyclin D1 and cyclin E mRNAs are not affected for up to 8 h
by TH, RA, or PDGF withdrawal. Whereas PDGF with-
drawal causes a rapid fall in cyclin D2 mRNA, TH or RA
treatment does not. Interestingly, both PDGF withdrawal
and TH treatment, but not RA treatment, induce an in-
crease in cyclin D3 mRNA at 4 and 8 h, indicating that TH
and RA do not act identically on oligodendrocyte precursor
Copyright © 1999 by Academic Press. All rightcells. It is possible that RA treatment also increases cyclin
D3 mRNA but on a slower time scale. Cyclin D3 is the
most widely expressed cyclin D family member in mam-
mals (Bartkova et al., 1998). Although it seems to be
required for G1 progression in some human and rat fibro-
blast cell lines (Bartkova et al., 1998), it has been shown to
increase when some myoblast cell lines (Jahn et al., 1994;
Kiess et al., 1995; Rao and Kohtz, 1995) and the human
promyelocytic leukaemia line HL 60 (Bartkova et al., 1998)
stop dividing and differentiate. Whether cyclin D3 plays a
part in the differentiation process in these cells or any
others is unknown.
Although it is uncertain whether RA normally regulates
oligodendrocyte differentiation in vivo, TH seems to act at
many stages of oligodendrocyte development, including the
commitment of multipotential stem cells to the oligoden-
drocyte lineage (Johe et al., 1996), the timing of the initia-
tion of oligodendrocyte precursor differentiation (Ahlgren
et al., 1997; Barres et al., 1994; Ibarolla et al., 1996), and the
later expression of the genes that encode various myelin
proteins (Farsetti et al., 1991; Figueiredo et al., 1993;
Lopez-Barahona et al., 1993; Rodriguez-Pena et al., 1993;
Shanker et al., 1987; Tosic et al., 1992). TH also influences
the timing of differentiation of many other types of verte-
brate cells, suggesting that it helps coordinate the timing of
cell differentiation in tissues throughout the body, just as it
coordinates the events of amphibian metamorphosis (Wang
and Brown, 1993). It remains a major challenge to under-
stand how TH acts to regulate the timing of differentiation
in each of these cell lineages. Having failed to discover any
genes that are directly regulated by TH or RA in oligoden-
drocyte precursor cells by analyzing known candidates, we
are currently using subtractive hybridization to look for
primary response genes that are directly regulated by both
TH and RA.
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